Skip to content
Back to Top

Alaska Prescription Drug Monitoring Program

Confidential Prescriber Report Notice from December 6, 2017:

Effective July, 2017, House Bill 159 added a new section, AS 17.30.200(t) authorizing unsolicited issuance of confidential prescriber reports "report cards" to be sent periodically to prescribers required to register with the Prescription Drug Monitoring Program (PDMP).

On behalf of the PDMP, report cards were sent to individual prescribers on December 6, 2017 along with an email explaining the report measures and a description of the metrics. The report card offers prescribers the opportunity to review prescribing patterns in relation to the average data of other prescribers within the same specialty type. For information on how to interpret these report metrics, please click HERE. FAQs regarding this notice can be found HERE.

Please contact if the report reflects a different primary health care specialty in which you are currently practicing or if you have not received this notice via email.

How to use the Alaska Prescription Drug Monitoring Program

The Alaska Prescription Drug Monitoring Program (AKPDMP) is Alaska's solution for monitoring Schedule II-IV controlled substances dispensed in Alaska. This program is designed to improve patient care and foster the goal of reducing misuse, abuse, and diversion of controlled substances; and to encourage cooperation and coordination among state, local, and federal agencies and other states to reduce the misuse, abuse, and diversion of controlled substances.

AS 17.30.200 requires that each dispenser shall submit, by electronic means, information regarding each prescription dispensed for a controlled substance. Each dispenser shall submit the required information to the central repository at least once each week unless the board waives this requirement for good cause shown by the dispensing vendor.

                           PDMP Instructions and Resources
Online Icon
      PDMP Notification FAQs
Online Icon
      PDMP sign-in by AWARxE     (same email used to create your PDMP account)
Online Icon
      Create a PDMP account in AWARxE
      (register with the same name as it appears on your professional license)
Online Icon
      Provider sign-up instructions
Online Icon
      Delegate sign-up instructions
Online Icon
      Patient request guide
Online Icon
      Data submission dispenser guide
Online Icon
      Submit data through the PMP clearing house

HB 159

PDMP Registration Requirements for Prescribers, Pharmacists and Delegates

Comprehensive Guide to PDMP Requirements and Effective Dates

Opioid Prescribing Statement

Starting July 17, 2017:

  • Mandatory registration by all pharmacists who dispense a federally controlled substances II, III and IV and DEA registered prescribers licensed in the State of Alaska.
  • Practitioner must review PDMP information before dispensing, prescribing, or administering a federal schedule II or III controlled substance. The exception(s) are:
    • receiving treatment in an inpatient setting;
    • at the scene of an emergency or in an ambulance;
    • in an emergency room;
    • immediately before, during, or within the first 48 hours after surgery or a medical procedure;
    • in a hospice or nursing home that has an in house pharmacy;
    • a nonrefillable prescription of a controlled substance in a quantity intended to last for not more than three days.
  • Collection of all schedule II, III, or IV controlled substances dispensed in the state; schedule V controlled substances are no longer collected.
  • Delegate access is now allowed, but with limitations; a registered pharmacist or prescriber may allow access to the PDMP by an agent or employee, who is licensed or registered under AS 08, by creating a sub-account within the PDMP under their corresponding prescriber or pharmacist account.
  • Unsolicited reports may be provided to both prescribers and pharmacists when a patient appears to be receiving multiple Schedule II-IV prescriptions from multiple pharmacies and multiple prescribers; the current threshold is set at 5 prescribers / 5 dispensers in a 3-month period.
  • Reporting frequency of controlled substances dispensed will change to weekly.

Joint Committee on Prescriptive Guidelines Report to Alaska State Legislature

Learn more about reducing addiction at: Opioids.Alaska.Gov

Alaska Prescription Drug monitoring Program


Legislative Reports

Contact Us

Technical Assistance
For help with the PDMP, please contact Appriss PMP AWARxE Technical Assistance at: 1-855-525-4767

Alaska Prescription Drug Monitoring Program
550 West 7th Avenue, Suite 1500
Anchorage, Alaska 99501-3567
Telephone 907-269-8404
Fax 907-269-6003